Abstract

Shadnia et al. [11] 2012 100 7% Letter to the editor Tramadol is nowadays one of the most commonly abused drugs in Iran. In our country, few emergency physicians have never visited a tramadol-intoxicated patient referring after overdose or with side effects of its use. One of the complications of tramadol use, abuse, or overdose is seizure [1-4]. It has been shown that the tramadol-induced seizures are not dose-dependent [5]. To date, the incidence rate of recurrent/multiple seizures in tramadol-intoxicated patients has been determined in several studies as shown in Table 1 [3,6-11]. The important question is that is there a need for prophylactic administration of anticonvulsants in tramadolintoxicated patients referring with an initial seizure? Of note, in some poison treatment centers of Iran, administration of benzodiazepine is a routine treatment in such patients. As you know, in the setting of clinical toxicology, except for the intravenous overdose of vincristine [12], severe toxicity with methylxanthines [13], strychnine toxicity [14], and withdrawal of ethanol and some benzodiazepines [15], no other condition exists for whose prevention of recurrent or multiple seizures, prophylactic anticonvulsants have been recommended [16]. This certainly applies to the tramadol-induced seizures, as well, because these seizures have no special characteristic for which we believe them to be different from other drugand toxin-induced seizures. For instance, tramadol-induced seizures are tonic-clonic, short-lived, and self-limited similar to the most of other drug-induced seizures [16]. In addition, in the setting of poisoning, even where there is the likelihood of recurrent seizures (except for the above-mentioned conditions), prophylactic administration of the anticonvulsants has not been recommended and in the case of

Highlights

  • Obesity has reached epidemic proportions and is still escalating at an alarming rate worldwide

  • Obesity is associated with chronic activation of low-grade inflammation [3], which is implicated in the pathogenesis of obesity-associated diseases including insulin resistance, type-2 diabetes (T2D) [4, 5] and cardiovascular disease [6, 7]

  • A numerous of studies has been shown that shortchain fatty acids (SCFAs) inhibit inflammation with focus on butyrate and to a lesser extent on acetate and Propionic Acid (PA), [16]

Read more

Summary

Introduction

Obesity has reached epidemic proportions and is still escalating at an alarming rate worldwide. In Palestine the prevalence of obesity has been shown to be approximately 4. The etiology of obesity and low-grade inflammation is complex and involves intrinsic and extrinsic factors. The colonization of germ-free mice with microbiota derived from obese mice results in significantly greater adiposity than colonization with microbiota from lean mice [12]. Prebiotic diets such as fructans [13] are associated with general better health, including the decrease in body weight, fat mass and the severity of T2D [14,15,16]. The factors that influence the composition and metabolism of intestinal

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.